Business Context and Reporting Period
Company: Pacific Biosciences of California, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: August 2, 2017
Reporting Period: Second fiscal quarter ended June 30, 2017
This filing serves as a notification that the company announced its financial results for the second quarter of 2017. The detailed results are contained in a press release attached as Exhibit 99.1, which is incorporated by reference but explicitly furnished and not "filed" under the Exchange Act.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific financial data points. The following metrics are not present in the source text:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt Levels
- Liquidity Position
Note: Specific values for these metrics are located in the referenced Exhibit 99.1 (Press Release), which is not included in the input text.
Material Changes
The filing text does not provide specific data regarding material changes in financial performance compared to the prior comparable period. It only confirms the announcement of the Q2 2017 results.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It strictly references the existence of the press release containing the announcement.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 2, 2017) for actual revenue, net loss, and cash position figures.
- Verify the specific year-over-year and quarter-over-quarter growth rates mentioned in the press release.
- Check for any updated full-year 2017 guidance provided in the referenced press release.
- Confirm the status of the company's cash runway and burn rate as detailed in the full financial report.